Hegele R A
Department of Medicine, University of Toronto, Ontario, Canada.
Br J Hosp Med. 1995;54(4):143-6.
In order to enhance health care for patients with coronary heart disease (CHD), genetic markers of susceptibility could be incorporated into a formula for risk evaluation that includes traditional factors. Preventive measures could then be targeted towards 'high-risk' subjects. But can the genetic component be dissected from the environmental component in an intermediate CHD phenotype, such as plasma lipoproteins.
